|
OMIM |
Link |
Information gain |
01 |
|
SLE
|
[NCBI]
|
0.0126134
|
|
|
RA
|
[NCBI]
|
0.00681351
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
0.00552746
|
|
|
IGAD1
|
[NCBI]
|
0.00443254
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00296604
|
|
|
storage pool platelet disease
|
[NCBI]
|
0.00280298
|
|
|
cryoglobulinemia, familial mixed
|
[NCBI]
|
0.00220238
|
|
|
SPS
|
[NCBI]
|
0.00207888
|
|
|
IGAN1
|
[NCBI]
|
0.00191851
|
|
|
Sf
|
[NCBI]
|
0.00172585
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.00141343
|
|
|
TNF
|
[NCBI]
|
0.00115155
|
|
|
AD
|
[NCBI]
|
0.00104706
|
|
|
lymphangiectasia, intestinal
|
[NCBI]
|
0.000888406
|
|
|
kabuki syndrome
|
[NCBI]
|
0.000796906
|
|
|
CVID
|
[NCBI]
|
0.000743642
|
|
|
inclusion body myositis
|
[NCBI]
|
0.000665449
|
|
|
neutrophilic dermatosis, acute febrile
|
[NCBI]
|
0.000615219
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.000615219
|
|
|
proteus syndrome
|
[NCBI]
|
0.000571792
|
|
|
APS2
|
[NCBI]
|
0.000571792
|
|
|
CF
|
[NCBI]
|
0.00056406
|
|
|
CD
|
[NCBI]
|
0.000519011
|
|
|
MG
|
[NCBI]
|
0.000509255
|
|
|
sjogren syndrome
|
[NCBI]
|
0.000441629
|
|
|
MBP
|
[NCBI]
|
0.000432098
|
|
|
PD
|
[NCBI]
|
0.000419209
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000416449
|
|
|
TG
|
[NCBI]
|
0.000410921
|
|
|
FA
|
[NCBI]
|
0.000391118
|
|
|
APC
|
[NCBI]
|
0.0003874
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.000334008
|
|
|
DSG3
|
[NCBI]
|
0.000285195
|
|
|
MPO
|
[NCBI]
|
0.000260997
|
|
|
hyperimmunoglobulin g1(a1) syndrome
|
[NCBI]
|
0.000216603
|
|
|
RP
|
[NCBI]
|
0.000202272
|
|
|
ALD
|
[NCBI]
|
0.000197698
|
|
|
ALB
|
[NCBI]
|
0.00019346
|
|
|
VRNI
|
[NCBI]
|
0.000190408
|
|
|
FMF
|
[NCBI]
|
0.000170459
|
|
|
TPO
|
[NCBI]
|
0.000167365
|
|
|
behcet syndrome
|
[NCBI]
|
0.00016666
|
|
|
HIGM1
|
[NCBI]
|
0.000165922
|
|
|
CEACAM5
|
[NCBI]
|
0.000162033
|
|
|
DSG1
|
[NCBI]
|
0.000146514
|
|
|
myeloma, multiple
|
[NCBI]
|
0.000141326
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000138854
|
|
|
GIST
|
[NCBI]
|
0.000134458
|
|
|
FCGRT
|
[NCBI]
|
0.000133983
|
|
|
MAG
|
[NCBI]
|
0.000117429
|
|
|
BL
|
[NCBI]
|
0.000111894
|
|
|
NPY
|
[NCBI]
|
0.000108979
|
|
|
hypoproteinemia, hypercatabolic
|
[NCBI]
|
0.000101858
|
|
|
icos deficiency
|
[NCBI]
|
0.000101858
|
|
|
cirrhosis, familial
|
[NCBI]
|
0.000101858
|
|
|
heart block, congenital
|
[NCBI]
|
0.000100892
|
|
|
AVP
|
[NCBI]
|
8.51511e-05
|
|
|
IGHG1
|
[NCBI]
|
8.19784e-05
|
|
|
CHS
|
[NCBI]
|
7.32047e-05
|
|
|
PG
|
[NCBI]
|
7.2849e-05
|
|
|
gamma-a-globulin, defect in assembly of
|
[NCBI]
|
7.21929e-05
|
|
|
splenomegaly syndrome with splenic germinal center hypoplasia and reduced circulating t-helper cells
|
[NCBI]
|
7.21929e-05
|
|
|
pulmonary nodular lymphoid hyperplasia, familial
|
[NCBI]
|
7.21929e-05
|
|
|
immune deficiency, familial variable
|
[NCBI]
|
7.21929e-05
|
|
|
globulin anomaly involving beta (2a)-globulin
|
[NCBI]
|
7.21929e-05
|
|
|
lymphokine deficiency
|
[NCBI]
|
7.21929e-05
|
|
|
eosinophilopenia
|
[NCBI]
|
7.21929e-05
|
|
|
lymphoid system deterioration, progressive
|
[NCBI]
|
7.21929e-05
|
|
|
GTS
|
[NCBI]
|
7.14795e-05
|
|
|
TH
|
[NCBI]
|
7.01775e-05
|
|
|
MJD
|
[NCBI]
|
6.83155e-05
|
|
|
AR
|
[NCBI]
|
6.81692e-05
|
|
|
RNASE3
|
[NCBI]
|
6.44621e-05
|
|
|
SLEB1
|
[NCBI]
|
6.12816e-05
|
|
|
FCGR1A
|
[NCBI]
|
6.00925e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
5.84387e-05
|
|
|
PTH
|
[NCBI]
|
5.63249e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
5.50144e-05
|
|
|
CCK
|
[NCBI]
|
5.40474e-05
|
|
|
DFSP
|
[NCBI]
|
5.08236e-05
|
|
|
TLR9
|
[NCBI]
|
5.02274e-05
|
|
|
WAS
|
[NCBI]
|
4.90513e-05
|
|
|
HRG
|
[NCBI]
|
4.75715e-05
|
|
|
NPPA
|
[NCBI]
|
4.73271e-05
|
|
|
FCGR2A
|
[NCBI]
|
4.64201e-05
|
|
|
CFTR
|
[NCBI]
|
4.53986e-05
|
|
|
IGKC
|
[NCBI]
|
4.47096e-05
|
|
|
BOC
|
[NCBI]
|
4.46479e-05
|
|
|
ICOSLG
|
[NCBI]
|
4.36669e-05
|
|
|
ICOS
|
[NCBI]
|
4.36669e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
4.26105e-05
|
|
|
dermographism, familial
|
[NCBI]
|
4.15815e-05
|
|
|
persistent polyclonal b-cell lymphocytosis
|
[NCBI]
|
4.15815e-05
|
|
|
microcephaly with chemotactic defect and transient hypogammaglobulinemia
|
[NCBI]
|
4.15815e-05
|
|
|
myokymia with neonatal epilepsy
|
[NCBI]
|
4.15815e-05
|
|
|
CAT
|
[NCBI]
|
4.10405e-05
|
|
|
ARID4B
|
[NCBI]
|
4.00584e-05
|
|
|
LSAMP
|
[NCBI]
|
4.00584e-05
|
|
|
FCGR3A
|
[NCBI]
|
3.93184e-05
|
|
|
AFP
|
[NCBI]
|
3.78536e-05
|
|
|
PF4
|
[NCBI]
|
3.44069e-05
|
|
|
EIG
|
[NCBI]
|
3.35192e-05
|
|
|
IL4
|
[NCBI]
|
3.15701e-05
|
|
|
CRH
|
[NCBI]
|
3.15192e-05
|
|
|
IL2
|
[NCBI]
|
3.12251e-05
|
|
|
CDON
|
[NCBI]
|
3.09435e-05
|
|
|
AICDA
|
[NCBI]
|
3.0908e-05
|
|
|
EGF
|
[NCBI]
|
3.02895e-05
|
|
|
DHFR
|
[NCBI]
|
2.95195e-05
|
|
|
LPI
|
[NCBI]
|
2.85298e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
2.83016e-05
|
|
|
AMC
|
[NCBI]
|
2.79824e-05
|
|
|
NUDCD1
|
[NCBI]
|
2.7419e-05
|
|
|
cancer/testis antigen km-hn-1
|
[NCBI]
|
2.7419e-05
|
|
|
ACPP
|
[NCBI]
|
2.7385e-05
|
|
|
MIRN155
|
[NCBI]
|
2.7201e-05
|
|
|
IGHE
|
[NCBI]
|
2.62092e-05
|
|
|
MBL2
|
[NCBI]
|
2.58858e-05
|
|
|
STAT6
|
[NCBI]
|
2.48226e-05
|
|
|
TF
|
[NCBI]
|
2.41362e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
2.38737e-05
|
|
|
vitiligo
|
[NCBI]
|
2.38737e-05
|
|
|
PRL
|
[NCBI]
|
2.37813e-05
|
|
|
PSCA
|
[NCBI]
|
2.36157e-05
|
|
|
ACHE
|
[NCBI]
|
2.32916e-05
|
|
|
TBX21
|
[NCBI]
|
2.23488e-05
|
|
|
MOG
|
[NCBI]
|
2.17307e-05
|
|
|
TFPI
|
[NCBI]
|
2.14563e-05
|
|
|
CD40
|
[NCBI]
|
2.115e-05
|
|
|
PVR
|
[NCBI]
|
2.10608e-05
|
|
|
VEGF
|
[NCBI]
|
2.10525e-05
|
|
|
EV
|
[NCBI]
|
2.07836e-05
|
|
|
C3
|
[NCBI]
|
2.00708e-05
|
|
|
BCL2L12
|
[NCBI]
|
2.00276e-05
|
|
|
UTP14A
|
[NCBI]
|
2.00276e-05
|
|
|
CD37
|
[NCBI]
|
2.00276e-05
|
|
|
MYO18A
|
[NCBI]
|
2.00276e-05
|
|
|
fc fragment of iga and igm, receptor for
|
[NCBI]
|
2.00276e-05
|
|
|
IGHG2
|
[NCBI]
|
2.00276e-05
|
|
|
POLQ
|
[NCBI]
|
2.00276e-05
|
|
|
PIGR
|
[NCBI]
|
1.98013e-05
|
|
|
APOE
|
[NCBI]
|
1.97e-05
|
|
|
APCS
|
[NCBI]
|
1.96036e-05
|
|
|
graves disease
|
[NCBI]
|
1.94197e-05
|
|
|
TNFSF11
|
[NCBI]
|
1.92032e-05
|
|
|
YT
|
[NCBI]
|
1.90956e-05
|
|
|
PPNAD1
|
[NCBI]
|
1.90956e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.90928e-05
|
|
|
AQP4
|
[NCBI]
|
1.87193e-05
|
|
|
ECM1
|
[NCBI]
|
1.86829e-05
|
|
|
HP
|
[NCBI]
|
1.83383e-05
|
|
|
EGFR
|
[NCBI]
|
1.83126e-05
|
|
|
ANXA5
|
[NCBI]
|
1.78535e-05
|
|
|
ICAM3
|
[NCBI]
|
1.72577e-05
|
|
|
SIGLEC8
|
[NCBI]
|
1.72577e-05
|
|
|
IGHG4
|
[NCBI]
|
1.72577e-05
|
|
|
CLCF1
|
[NCBI]
|
1.72577e-05
|
|
|
single-strand-selective monofunctional uracil-dna glycosylase 1
|
[NCBI]
|
1.72577e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.71867e-05
|
|
|
ALPS
|
[NCBI]
|
1.70309e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
1.6979e-05
|
|
|
SLC4A1
|
[NCBI]
|
1.67569e-05
|
|
|
COL17A1
|
[NCBI]
|
1.63914e-05
|
|
|
B2M
|
[NCBI]
|
1.6227e-05
|
|
|
IL10
|
[NCBI]
|
1.58869e-05
|
|
|
IFNA1
|
[NCBI]
|
1.5835e-05
|
|
|
TNFSF8
|
[NCBI]
|
1.5741e-05
|
|
|
ragweed sensitivity
|
[NCBI]
|
1.54868e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
1.54868e-05
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
1.54868e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
1.54868e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
1.54868e-05
|
|
|
IGHG3
|
[NCBI]
|
1.54702e-05
|
|
|
IGHA1
|
[NCBI]
|
1.54702e-05
|
|
|
VEGFC
|
[NCBI]
|
1.54702e-05
|
|
|
DPYSL5
|
[NCBI]
|
1.54702e-05
|
|
|
CHRNA9
|
[NCBI]
|
1.54702e-05
|
|
|
TNFRSF21
|
[NCBI]
|
1.54702e-05
|
|
|
WIF1
|
[NCBI]
|
1.54702e-05
|
|
|
pcna-associated factor, 15-kd
|
[NCBI]
|
1.54702e-05
|
|
|
BACH2
|
[NCBI]
|
1.54702e-05
|
|
|
NUCB1
|
[NCBI]
|
1.54702e-05
|
|
|
SH2D2A
|
[NCBI]
|
1.54702e-05
|
|
|
TIE1
|
[NCBI]
|
1.54702e-05
|
|
|
WT1
|
[NCBI]
|
1.533e-05
|
|
|
HLA-A
|
[NCBI]
|
1.43261e-05
|
|
|
RAET1E
|
[NCBI]
|
1.41492e-05
|
|
|
CDR1
|
[NCBI]
|
1.41492e-05
|
|
|
POU2F2
|
[NCBI]
|
1.41492e-05
|
|
|
RPS20
|
[NCBI]
|
1.41492e-05
|
|
|
CCDC88A
|
[NCBI]
|
1.41492e-05
|
|
|
TNFRSF17
|
[NCBI]
|
1.41492e-05
|
|
|
LILRB4
|
[NCBI]
|
1.41492e-05
|
|
|
mas20p, s. cerevisiae, homolog of
|
[NCBI]
|
1.41492e-05
|
|
|
IBD1
|
[NCBI]
|
1.41222e-05
|
|
|
SLAMF1
|
[NCBI]
|
1.40379e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
1.36223e-05
|
|
|
COMP
|
[NCBI]
|
1.34216e-05
|
|
|
IL13
|
[NCBI]
|
1.3299e-05
|
|
|
CD24
|
[NCBI]
|
1.3103e-05
|
|
|
LMF1
|
[NCBI]
|
1.3103e-05
|
|
|
BAD
|
[NCBI]
|
1.3103e-05
|
|
|
MSH5
|
[NCBI]
|
1.3103e-05
|
|
|
TROVE2
|
[NCBI]
|
1.3103e-05
|
|
|
IGHA2
|
[NCBI]
|
1.3103e-05
|
|
|
switch-associated protein 70
|
[NCBI]
|
1.3103e-05
|
|
|
SSB
|
[NCBI]
|
1.3103e-05
|
|
|
AGER
|
[NCBI]
|
1.29738e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.28405e-05
|
|
|
PCNA
|
[NCBI]
|
1.27762e-05
|
|
|
CNTF
|
[NCBI]
|
1.27331e-05
|
|
|
GS2
|
[NCBI]
|
1.26508e-05
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
1.26508e-05
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
1.26508e-05
|
|
|
TTR
|
[NCBI]
|
1.25532e-05
|
|
|
MS
|
[NCBI]
|
1.25477e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.25122e-05
|
|
|
TLR2
|
[NCBI]
|
1.24195e-05
|
|
|
TMEFF2
|
[NCBI]
|
1.22384e-05
|
|
|
PRKCB1
|
[NCBI]
|
1.22384e-05
|
|
|
XRCC4
|
[NCBI]
|
1.22384e-05
|
|
|
CD22
|
[NCBI]
|
1.22384e-05
|
|
|
FCER1G
|
[NCBI]
|
1.22384e-05
|
|
|
HPA-2
|
[NCBI]
|
1.22384e-05
|
|
|
LCP2
|
[NCBI]
|
1.22384e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.20763e-05
|
|
|
CSF2
|
[NCBI]
|
1.17959e-05
|
|
|
MAPK14
|
[NCBI]
|
1.17959e-05
|
|
|
C4B
|
[NCBI]
|
1.16025e-05
|
|
|
LIPG
|
[NCBI]
|
1.15029e-05
|
|
|
F2RL2
|
[NCBI]
|
1.15029e-05
|
|
|
RPS13
|
[NCBI]
|
1.15029e-05
|
|
|
TNFSF7
|
[NCBI]
|
1.15029e-05
|
|
|
DEFA3
|
[NCBI]
|
1.15029e-05
|
|
|
TAPBP
|
[NCBI]
|
1.15029e-05
|
|
|
HYAL2
|
[NCBI]
|
1.15029e-05
|
|
|
LPL
|
[NCBI]
|
1.14514e-05
|
|
|
COL7A1
|
[NCBI]
|
1.14137e-05
|
|
|
TLR5
|
[NCBI]
|
1.14137e-05
|
|
|
CCL21
|
[NCBI]
|
1.12294e-05
|
|
|
POU2AF1
|
[NCBI]
|
1.08639e-05
|
|
|
C1QR1
|
[NCBI]
|
1.08639e-05
|
|
|
IL21R
|
[NCBI]
|
1.08639e-05
|
|
|
FCAR
|
[NCBI]
|
1.08639e-05
|
|
|
TEK
|
[NCBI]
|
1.08639e-05
|
|
|
DNASE1
|
[NCBI]
|
1.08639e-05
|
|
|
PRKCD
|
[NCBI]
|
1.08639e-05
|
|
|
FRAP1
|
[NCBI]
|
1.07518e-05
|
|
|
HAE
|
[NCBI]
|
1.06611e-05
|
|
|
SH2D1A
|
[NCBI]
|
1.05333e-05
|
|
|
PBC
|
[NCBI]
|
1.0364e-05
|
|
|
GS1
|
[NCBI]
|
1.0364e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
1.0364e-05
|
|
|
RCV1
|
[NCBI]
|
1.02997e-05
|
|
|
EFNA5
|
[NCBI]
|
1.02997e-05
|
|
|
FCER1A
|
[NCBI]
|
1.02997e-05
|
|
|
DSG4
|
[NCBI]
|
1.02997e-05
|
|
|
DSC3
|
[NCBI]
|
1.02997e-05
|
|
|
GAS6
|
[NCBI]
|
1.02997e-05
|
|
|
SDS
|
[NCBI]
|
1.01106e-05
|
|
|
EPO
|
[NCBI]
|
1.00107e-05
|
|
|
NFE2L2
|
[NCBI]
|
9.79541e-06
|
|
|
CXCL10
|
[NCBI]
|
9.79541e-06
|
|
|
A4GALT
|
[NCBI]
|
9.79541e-06
|
|
|
FSTL1
|
[NCBI]
|
9.79541e-06
|
|
|
complement component c1r deficiency
|
[NCBI]
|
9.79541e-06
|
|
|
CCL4
|
[NCBI]
|
9.79541e-06
|
|
|
CCL5
|
[NCBI]
|
9.79541e-06
|
|
|
BCL2
|
[NCBI]
|
9.59713e-06
|
|
|
IP
|
[NCBI]
|
9.56831e-06
|
|
|
RNASE2
|
[NCBI]
|
9.54735e-06
|
|
|
PAG1
|
[NCBI]
|
9.34e-06
|
|
|
PLA2G4A
|
[NCBI]
|
9.34e-06
|
|
|
FABP7
|
[NCBI]
|
9.34e-06
|
|
|
FYB
|
[NCBI]
|
9.34e-06
|
|
|
MATN1
|
[NCBI]
|
9.34e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
9.19153e-06
|
|
|
A2M
|
[NCBI]
|
9.17074e-06
|
|
|
TTP
|
[NCBI]
|
9.06797e-06
|
|
|
CALR
|
[NCBI]
|
8.92532e-06
|
|
|
HDAC5
|
[NCBI]
|
8.92532e-06
|
|
|
CKM
|
[NCBI]
|
8.92532e-06
|
|
|
PYY
|
[NCBI]
|
8.80493e-06
|
|
|
SHH
|
[NCBI]
|
8.61999e-06
|
|
|
CCL3
|
[NCBI]
|
8.54507e-06
|
|
|
ADD1
|
[NCBI]
|
8.54507e-06
|
|
|
INDO
|
[NCBI]
|
8.54507e-06
|
|
|
OLR1
|
[NCBI]
|
8.54507e-06
|
|
|
PVRL1
|
[NCBI]
|
8.54507e-06
|
|
|
SCAR1
|
[NCBI]
|
8.48778e-06
|
|
|
CGA
|
[NCBI]
|
8.19433e-06
|
|
|
CBP2
|
[NCBI]
|
8.19433e-06
|
|
|
GRM1
|
[NCBI]
|
8.19433e-06
|
|
|
MBD2
|
[NCBI]
|
8.19433e-06
|
|
|
HIC1
|
[NCBI]
|
8.19433e-06
|
|
|
RTN1
|
[NCBI]
|
7.86914e-06
|
|
|
ITGA2
|
[NCBI]
|
7.86914e-06
|
|
|
RGMA
|
[NCBI]
|
7.86914e-06
|
|
|
LIG4
|
[NCBI]
|
7.86914e-06
|
|
|
TGFB1
|
[NCBI]
|
7.79979e-06
|
|
|
ACP5
|
[NCBI]
|
7.75191e-06
|
|
|
SLPI
|
[NCBI]
|
7.64219e-06
|
|
|
OCP
|
[NCBI]
|
7.62508e-06
|
|
|
DSG2
|
[NCBI]
|
7.56632e-06
|
|
|
NPHS1
|
[NCBI]
|
7.56632e-06
|
|
|
PDCD1
|
[NCBI]
|
7.56632e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
7.30238e-06
|
|
|
CAST
|
[NCBI]
|
7.28322e-06
|
|
|
S100A8
|
[NCBI]
|
7.28322e-06
|
|
|
IL7
|
[NCBI]
|
7.28322e-06
|
|
|
POLD1
|
[NCBI]
|
7.28322e-06
|
|
|
IL17A
|
[NCBI]
|
7.28322e-06
|
|
|
LTF
|
[NCBI]
|
7.28322e-06
|
|
|
RTN4
|
[NCBI]
|
7.28322e-06
|
|
|
APOA4
|
[NCBI]
|
7.28322e-06
|
|
|
GPR24
|
[NCBI]
|
7.28322e-06
|
|
|
CLDN11
|
[NCBI]
|
7.28322e-06
|
|
|
PIP
|
[NCBI]
|
7.28322e-06
|
|
|
F2R
|
[NCBI]
|
7.25983e-06
|
|
|
CCL2
|
[NCBI]
|
7.15718e-06
|
|
|
BCGF
|
[NCBI]
|
7.09737e-06
|
|
|
MME
|
[NCBI]
|
7.01765e-06
|
|
|
CGB
|
[NCBI]
|
7.01765e-06
|
|
|
IL15
|
[NCBI]
|
7.01765e-06
|
|
|
FLT4
|
[NCBI]
|
7.01765e-06
|
|
|
CXCL13
|
[NCBI]
|
7.01765e-06
|
|
|
FGB
|
[NCBI]
|
7.01765e-06
|
|
|
BTK
|
[NCBI]
|
6.95684e-06
|
|
|
HHS
|
[NCBI]
|
6.93035e-06
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
6.93035e-06
|
|
|
hemophilia a
|
[NCBI]
|
6.77697e-06
|
|
|
LGALS3
|
[NCBI]
|
6.76776e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
6.76776e-06
|
|
|
DEFA1
|
[NCBI]
|
6.76776e-06
|
|
|
CCR2
|
[NCBI]
|
6.53198e-06
|
|
|
SLC7A5
|
[NCBI]
|
6.53198e-06
|
|
|
LRP2
|
[NCBI]
|
6.30897e-06
|
|
|
EIF4G1
|
[NCBI]
|
6.09756e-06
|
|
|
ABCC3
|
[NCBI]
|
6.09756e-06
|
|
|
pta deficiency
|
[NCBI]
|
6.09756e-06
|
|
|
GAL3ST1
|
[NCBI]
|
6.09756e-06
|
|
|
ARNTL
|
[NCBI]
|
6.09756e-06
|
|
|
MRE11A
|
[NCBI]
|
6.09756e-06
|
|
|
EDA
|
[NCBI]
|
6.09756e-06
|
|
|
F3
|
[NCBI]
|
6.07733e-06
|
|
|
LAD
|
[NCBI]
|
6.03456e-06
|
|
|
BLM
|
[NCBI]
|
6.03456e-06
|
|
|
GNRH1
|
[NCBI]
|
5.93008e-06
|
|
|
SELP
|
[NCBI]
|
5.89674e-06
|
|
|
NRP1
|
[NCBI]
|
5.89674e-06
|
|
|
PDGFRB
|
[NCBI]
|
5.89674e-06
|
|
|
IL6
|
[NCBI]
|
5.89556e-06
|
|
|
PTK2
|
[NCBI]
|
5.62814e-06
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
5.62755e-06
|
|
|
sandhoff disease
|
[NCBI]
|
5.57214e-06
|
|
|
ADAMTS13
|
[NCBI]
|
5.52346e-06
|
|
|
TSG101
|
[NCBI]
|
5.52346e-06
|
|
|
KLK3
|
[NCBI]
|
5.48083e-06
|
|
|
PMP22
|
[NCBI]
|
5.3682e-06
|
|
|
APOB
|
[NCBI]
|
5.2777e-06
|
|
|
FGFR4
|
[NCBI]
|
5.18323e-06
|
|
|
ELA2
|
[NCBI]
|
5.02402e-06
|
|
|
LDHB
|
[NCBI]
|
5.02402e-06
|
|
|
ITGA2B
|
[NCBI]
|
5.02402e-06
|
|
|
SCIDX1
|
[NCBI]
|
4.99653e-06
|
|
|
LSA
|
[NCBI]
|
4.99653e-06
|
|
|
SRC
|
[NCBI]
|
4.90844e-06
|
|
|
CD44
|
[NCBI]
|
4.87141e-06
|
|
|
IFNGR1
|
[NCBI]
|
4.87141e-06
|
|
|
COL4A3
|
[NCBI]
|
4.72496e-06
|
|
|
TNFRSF6B
|
[NCBI]
|
4.72496e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
4.72496e-06
|
|
|
MVK
|
[NCBI]
|
4.72496e-06
|
|
|
ADCYAP1
|
[NCBI]
|
4.66336e-06
|
|
|
HGFAC
|
[NCBI]
|
4.58427e-06
|
|
|
LYZ
|
[NCBI]
|
4.58427e-06
|
|
|
RTN4R
|
[NCBI]
|
4.58427e-06
|
|
|
SLC3A2
|
[NCBI]
|
4.58427e-06
|
|
|
autoimmune disease
|
[NCBI]
|
4.53289e-06
|
|
|
CD40LG
|
[NCBI]
|
4.44899e-06
|
|
|
DNMT3B
|
[NCBI]
|
4.19333e-06
|
|
|
IKBKG
|
[NCBI]
|
4.07239e-06
|
|
|
APOH
|
[NCBI]
|
4.07239e-06
|
|
|
TIMP1
|
[NCBI]
|
3.95571e-06
|
|
|
CREM
|
[NCBI]
|
3.95571e-06
|
|
|
PTX3
|
[NCBI]
|
3.84304e-06
|
|
|
LTA
|
[NCBI]
|
3.84304e-06
|
|
|
GHRL
|
[NCBI]
|
3.84304e-06
|
|
|
AGTR1
|
[NCBI]
|
3.52714e-06
|
|
|
TNFSF13B
|
[NCBI]
|
3.52714e-06
|
|
|
PROS1
|
[NCBI]
|
3.52714e-06
|
|
|
GPI
|
[NCBI]
|
3.47239e-06
|
|
|
aHUS
|
[NCBI]
|
3.45314e-06
|
|
|
temporal arteritis
|
[NCBI]
|
3.44776e-06
|
|
|
LIFR
|
[NCBI]
|
3.4286e-06
|
|
|
CYP3A4
|
[NCBI]
|
3.4286e-06
|
|
|
PTPRC
|
[NCBI]
|
3.4286e-06
|
|
|
TLR4
|
[NCBI]
|
3.4145e-06
|
|
|
TNFSF6
|
[NCBI]
|
3.28188e-06
|
|
|
CTLA4
|
[NCBI]
|
3.24071e-06
|
|
|
fucosidosis
|
[NCBI]
|
3.24071e-06
|
|
|
HHC1
|
[NCBI]
|
3.07262e-06
|
|
|
TNFRSF6
|
[NCBI]
|
3.06415e-06
|
|
|
PLG
|
[NCBI]
|
2.91101e-06
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
2.83676e-06
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
2.83676e-06
|
|
|
DMPK
|
[NCBI]
|
2.81847e-06
|
|
|
SCP2
|
[NCBI]
|
2.74126e-06
|
|
|
RHCE
|
[NCBI]
|
2.74126e-06
|
|
|
LPO
|
[NCBI]
|
2.6696e-06
|
|
|
IFNG
|
[NCBI]
|
2.66623e-06
|
|
|
SOD2
|
[NCBI]
|
2.66435e-06
|
|
|
CD47
|
[NCBI]
|
2.59331e-06
|
|
|
KDR
|
[NCBI]
|
2.59189e-06
|
|
|
HGF
|
[NCBI]
|
2.4802e-06
|
|
|
CYP2D6
|
[NCBI]
|
2.45345e-06
|
|
|
STAT3
|
[NCBI]
|
2.40961e-06
|
|
|
FH
|
[NCBI]
|
2.38636e-06
|
|
|
WT1
|
[NCBI]
|
2.38636e-06
|
|
|
INS
|
[NCBI]
|
2.35586e-06
|
|
|
ITGB2
|
[NCBI]
|
2.32108e-06
|
|
|
CHAT
|
[NCBI]
|
2.30751e-06
|
|
|
UNG
|
[NCBI]
|
2.25753e-06
|
|
|
PROCR
|
[NCBI]
|
2.19566e-06
|
|
|
RLBP1
|
[NCBI]
|
2.19566e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
2.18754e-06
|
|
|
EAOH
|
[NCBI]
|
2.18754e-06
|
|
|
SPP1
|
[NCBI]
|
2.107e-06
|
|
|
CP
|
[NCBI]
|
2.09901e-06
|
|
|
NGFR
|
[NCBI]
|
2.09732e-06
|
|
|
F13A1
|
[NCBI]
|
2.07673e-06
|
|
|
CFB
|
[NCBI]
|
2.07673e-06
|
|
|
UMOD
|
[NCBI]
|
2.07673e-06
|
|
|
BDNF
|
[NCBI]
|
2.06082e-06
|
|
|
RASA1
|
[NCBI]
|
2.04074e-06
|
|
|
CTGF
|
[NCBI]
|
1.86714e-06
|
|
|
PNMT
|
[NCBI]
|
1.83814e-06
|
|
|
GRB2
|
[NCBI]
|
1.80506e-06
|
|
|
NP
|
[NCBI]
|
1.75476e-06
|
|
|
AT
|
[NCBI]
|
1.75301e-06
|
|
|
ITGB3
|
[NCBI]
|
1.65786e-06
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
1.64712e-06
|
|
|
SOCS3
|
[NCBI]
|
1.6112e-06
|
|
|
PI
|
[NCBI]
|
1.43991e-06
|
|
|
NMU
|
[NCBI]
|
1.43562e-06
|
|
|
SPARC
|
[NCBI]
|
1.43562e-06
|
|
|
JAK3
|
[NCBI]
|
1.43562e-06
|
|
|
G6PD
|
[NCBI]
|
1.39606e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.39435e-06
|
|
|
PENK
|
[NCBI]
|
1.31476e-06
|
|
|
THPO
|
[NCBI]
|
1.31476e-06
|
|
|
NR1I2
|
[NCBI]
|
1.30093e-06
|
|
|
ANG
|
[NCBI]
|
1.23892e-06
|
|
|
IAPP
|
[NCBI]
|
1.17946e-06
|
|
|
MVP
|
[NCBI]
|
1.1318e-06
|
|
|
factor v deficiency
|
[NCBI]
|
1.09777e-06
|
|
|
TSHR
|
[NCBI]
|
1.09777e-06
|
|
|
IDUA
|
[NCBI]
|
1.06456e-06
|
|
|
APS1
|
[NCBI]
|
1.01828e-06
|
|
|
VIP
|
[NCBI]
|
9.7573e-07
|
|
|
ZFP36
|
[NCBI]
|
9.09899e-07
|
|
|
LRP1
|
[NCBI]
|
8.96209e-07
|
|
|
hodgkin lymphoma
|
[NCBI]
|
8.40557e-07
|
|
|
STC1
|
[NCBI]
|
8.25639e-07
|
|
|
MPZ
|
[NCBI]
|
8.25639e-07
|
|
|
CDK2
|
[NCBI]
|
8.02552e-07
|
|
|
PLTP
|
[NCBI]
|
7.64478e-07
|
|
|
LAT
|
[NCBI]
|
7.47268e-07
|
|
|
CLL
|
[NCBI]
|
6.99407e-07
|
|
|
AIRE
|
[NCBI]
|
6.06738e-07
|
|
|
GABEB
|
[NCBI]
|
5.53859e-07
|
|
|
blood group, p system
|
[NCBI]
|
5.53859e-07
|
|
|
XLP1
|
[NCBI]
|
5.53859e-07
|
|
|
LIPC
|
[NCBI]
|
5.43934e-07
|
|
|
LKS
|
[NCBI]
|
5.05225e-07
|
|
|
giant platelet syndrome
|
[NCBI]
|
4.90577e-07
|
|
|
GFAP
|
[NCBI]
|
4.2728e-07
|
|
|
NRCLP1
|
[NCBI]
|
3.3914e-07
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
3.3914e-07
|
|
|
HDAC1
|
[NCBI]
|
3.36151e-07
|
|
|
PTHLH
|
[NCBI]
|
3.08816e-07
|
|
|
ADA
|
[NCBI]
|
2.92409e-07
|
|
|
ALK
|
[NCBI]
|
2.69636e-07
|
|
|
CCND1
|
[NCBI]
|
2.43027e-07
|
|
|
VIM
|
[NCBI]
|
2.31225e-07
|
|
|
CHAC
|
[NCBI]
|
2.03234e-07
|
|
|
OSM
|
[NCBI]
|
1.87406e-07
|
|
|
GAPDH
|
[NCBI]
|
1.69009e-07
|
|
|
CHH
|
[NCBI]
|
1.22278e-07
|
|
|
EPOR
|
[NCBI]
|
1.07367e-07
|
|
|
von willebrand disease
|
[NCBI]
|
1.01037e-07
|
|
|
glycogen storage disease ib
|
[NCBI]
|
9.98291e-08
|
|
|
NGFB
|
[NCBI]
|
9.92309e-08
|
|
|
PLAUR
|
[NCBI]
|
9.40424e-08
|
|
|
APP
|
[NCBI]
|
5.33485e-08
|
|
|
MAP2
|
[NCBI]
|
4.51002e-08
|
|
|
MB
|
[NCBI]
|
4.41382e-08
|
|
|
UCP1
|
[NCBI]
|
4.33738e-08
|
|
|
HEMB
|
[NCBI]
|
4.16035e-08
|
|
|
MCP
|
[NCBI]
|
4.16035e-08
|
|
|
BCHE
|
[NCBI]
|
3.65802e-08
|
|
|
TNFSF10
|
[NCBI]
|
3.34731e-08
|
|
|
PTEN
|
[NCBI]
|
2.75021e-08
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
1.23097e-08
|
|
|
GC
|
[NCBI]
|
8.71951e-09
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
1.24946e-09
|
|
|
HIDS
|
[NCBI]
|
1.24946e-09
|
|
|
PLK1
|
[NCBI]
|
1.0869e-09
|
|